Conference Support: The 13th International Drug Delivery Symposium

会议支持：第13届国际药物递送研讨会

• 批准号: 7267570
• 负责人: DAVID W GRAINGER
• 金额: $ 1.1万
• 依托单位: UNIVERSITY OF UTAH
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-02-23 至 2008-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7267570
• 关键词: Address; Area; Award; Biocompatible Materials; Biomedical Engineering; Biotechnology; Characteristics; Cities; Class; Clinical; Disease; Drug Delivery Systems; Drug Formulations; Faculty; Gender; Gene Delivery; Image; International; Leadership; Molecular; Oral; Participant; Penetration; Persons; Pharmaceutical Preparations; Pharmacologic Substance; Population; Research; Research Personnel; Scientist; Sodium Chloride; Solutions; Students; Thinking; Tissue Engineering; Tissues; Translational Research; Travel; Treatment Efficacy; Underrepresented Minority; Work; clinical application; cost; design; fundamental research; novel; posters; programs; symposium

DESCRIPTION (provided by applicant): This proposal by the Program Co-Chair (as PI) seeks support of selected junior and protected-class podium speakers, and 3 graduate student poster research presentation awards at the Thirteenth International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, UT, February 26-28, 2007. The general theme of the 2007 technical drug delivery conference is centered on "overcoming long-standing barriers", more specifically focused on addressing molecular, cellular and tissue barriers to effective drug targeting, penetration, formulation, and efficacy. The program design maintains its highly regarded tradition in assembling oral sessions comprising world-renowned pharmaceutical scientists, bioengineers, industrial scientists, and clinicians all seeking solutions to compelling drug delivery problems. Overall specific aims in producing this meeting are to: 1) Provide a rich, diverse scientific program focusing on both fundamental and clinical phenomena that limit drug therapeutic efficacy in several important disease contexts (i.e., hurdles of translational research), as well as key areas of biotechnology where investigators are proposing solutions to drug delivery, imaging, tissue engineering problems; 2) Gather a group of presenters and participants comprising widely acknowledged thought-leaders as well as younger, aggressive, and vibrant faculty and research trainees already noted for novel and quality work. Speakers and session chairs will represent both academic and commercial drug delivery efforts: perspectives and leadership from both fundamental research and clinical applications. The program is already mature and detailed herein, including persons from underrepresented scientific groups. Emphasis will be placed on supporting the more junior participants and under-represented populations involved in these areas. This group will similarly represent the gender diversity characteristic of faculty working in these areas; 3) Facilitate interactions between junior and under-represented minority scientists and faculty working in the formulation, biotechnology, gene delivery, biomaterials, drug targeting, bio-conjugation and imaging areas with prominent senior and international investigators in the field. Support is requested both for selected speaker participation costs and 3 junior scientist poster travel awards.

说明（由申请人提供）：项目联合主席（作为 PI）的这项提案寻求选定的初级和受保护级别讲台演讲者的支持，以及 2007 年 2 月 26-28 日在犹他州盐湖城举行的第十三届药物输送系统最新进展国际研讨会上的 3 个研究生海报研究报告奖。2007 年技术药物输送会议的总主题是“克服长期存在的障碍”，更具体地说 专注于解决有效药物靶向、渗透、配方和功效的分子、细胞和组织障碍。 该项目的设计保持了其备受推崇的传统，由世界著名的制药科学家、生物工程师、工业科学家和临床医生组成的口头会议，他们都在寻求解决紧迫的药物输送问题的方法。 举办这次会议的总体具体目标是： 1) 提供丰富、多样化的科学计划，重点关注在几种重要疾病背景下限制药物治疗效果的基本和临床现象（即转化研究的障碍），以及研究人员提出药物输送、成像、组织工程问题解决方案的生物技术关键领域； 2) 聚集一组演讲者和参与者，其中包括广受认可的思想领袖，以及因新颖和高质量工作而闻名的年轻、积极进取、充满活力的教员和研究实习生。演讲者和会议主席将代表学术和商业药物输送工作：基础研究和临床应用的观点和领导力。 该计划已经成熟且详细，其中包括来自代表性不足的科学团体的人员。重点将放在支持这些领域的初级参与者和代表性不足的人群。 该群体同样代表了在这些领域工作的教师的性别多样性特征； 3) 促进在配方、生物技术、基因传递、生物材料、药物靶向、生物共轭和成像领域工作的初级和代表性不足的少数族裔科学家和教师与该领域著名的高级和国际研究人员之间的互动。 请求支持选定的演讲者参与费用和 3 个初级科学家海报旅行奖。